McKhann Chas 4
4 · Apollo Endosurgery, Inc. · Filed Aug 20, 2021
Insider Transaction Report
Form 4
McKhann Chas
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2021-08-18$8.21/sh−21,156$173,691→ 686,122 total - Sale
Common Stock
2021-08-19$7.89/sh−21,148$166,858→ 664,974 total - Sale
Common Stock
2021-08-20$7.74/sh−21,148$163,686→ 643,826 total
Footnotes (3)
- [F1]Represents weighted average price of shares sold. Prices ranged between $8.02 - $8.55, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Represents weighted average price of shares sold. Prices ranged between $7.68 - $8.15, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Represents weighted average price of shares sold. Prices ranged between $7.59 - $8.09, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.